Gufic BioScience

{
  "main_header": {
    "sid": 338998,
    "name": "Gufic BioScience",
    "stock_name": "Gufic BioScience",
    "full_name": "Gufic BioSciences Ltd",
    "name_url": "stocks-analysis/gufic-bioscience",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "367.85",
    "chg": -1,
    "chgp": "-0.27%",
    "dir": -1,
    "prev_price": "368.85",
    "mcapval": "3,729.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 509079,
    "symbol": "GUFICBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE742B01025",
    "curr_date": "Jun 24, 03:30 PM",
    "curr_time": "19:16 PM",
    "last_traded_at": "Jun 24, 03:30 PM IST",
    "bse_nse_vol": "59.04 k",
    "exc_status": "Active",
    "traded_date": "Jun 24, 2026",
    "traded_date_str": "2026 06 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gufic-bioscience-338998-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Gufic BioSciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gufic-biosciences-ltd-is-rated-sell-4068917",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_mojoScore_4068917.png",
        "date": "2026-06-23 10:10:54",
        "description": "Gufic BioSciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 June 2026, providing investors with the most up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4054920",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_technicaldot_4054920.png",
        "date": "2026-06-16 08:01:56",
        "description": "Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflected in a downgrade of its Mojo Grade from Hold to Sell as of 11 June 2026. Despite a strong year-to-date return outperforming the Sensex, recent price action and technical indicators suggest a sideways trend with mixed signals, warranting a cautious stance among investors."
      },
      {
        "title": "Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4053386",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_technicaldot_4053386.png",
        "date": "2026-06-15 08:01:29",
        "description": "Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent upgrade in technical trend, the company’s overall MarketsMOJO grade has been downgraded from Hold to Sell, reflecting a complex interplay of bullish and bearish signals across multiple timeframes and indicators."
      },
      {
        "title": "Gufic BioSciences Gains 10.35%: 4 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-gains-1035-4-key-factors-driving-the-weeks-momentum-4052998",
        "imagepath": "",
        "date": "2026-06-14 12:04:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Stock surges 3.67% to ₹347.20 despite Sensex decline</p>\n                    <p><strong>2 June:</strong> Mixed technical signals amid mildly bearish momentum</p>\n                    <p><strong>3 June:</strong> Upgrade to Hold rating following strong quarterly results</p>\n                    <p><strong>4 June:</strong> Technical momentum shifts to mildly bullish with 3.73% gain</p>\n                    <p><strong>5 June:</strong> Week closes at ₹369.55, up 3.65% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.334.90</div></div>\n..."
      },
      {
        "title": "Gufic BioSciences Gains 0.47%: 3 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-gains-047-3-key-factors-driving-the-weeks-mixed-momentum-4051571",
        "imagepath": "",
        "date": "2026-06-13 14:04:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 June:</strong> Stock rallies 1.83% despite Sensex decline</p>\n                    <p><strong>9 June:</strong> Continued strong gains, up 3.10%</p>\n                    <p><strong>10 June:</strong> Sharp 6.33% drop amid valuation recalibration</p>\n                    <p><strong>11 June:</strong> Valuation shifts signal price attractiveness change</p>\n                    <p><strong>12 June:</strong> Downgrade to Sell and technical momentum shifts</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.369.55</div></div>\n                    <div class=\"stat-item\">..."
      },
      {
        "title": "Gufic BioSciences Ltd Downgraded to Sell Amid Mixed Technicals and Expensive Valuation",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gufic-biosciences-ltd-downgraded-to-sell-amid-mixed-technicals-and-expensive-valuation-4048334",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_mojoScore_4048334.png",
        "date": "2026-06-12 08:03:44",
        "description": "Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 11 June 2026. The downgrade follows a comprehensive reassessment across four critical parameters: Quality, Valuation, Financial Trend, and Technicals. Despite some positive quarterly results, the company faces challenges in sustaining long-term growth and valuation concerns amid mixed technical signals."
      },
      {
        "title": "Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4048243",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_technicaldot_4048243.png",
        "date": "2026-06-12 08:01:17",
        "description": "Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Recent technical indicators present a complex picture, with bullish signals on weekly charts contrasting bearish cues on monthly timeframes, prompting a reassessment of the stock’s near-term outlook."
      },
      {
        "title": "Gufic BioSciences Ltd Valuation Shifts Signal Price Attractiveness Change Amid Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-valuation-shifts-signal-price-attractiveness-change-amid-sector-dynamics-4045690",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_valuationdot_4045690.png",
        "date": "2026-06-11 08:00:18",
        "description": "Gufic BioSciences Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change reflects evolving market perceptions and impacts the stock’s price attractiveness relative to its historical levels and peer group within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Gufic BioSciences Ltd Upgraded to Hold as Financial and Technical Trends Improve",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gufic-biosciences-ltd-upgraded-to-hold-as-financial-and-technical-trends-improve-4035390",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_mojoScore_4035390.png",
        "date": "2026-06-04 08:07:40",
        "description": "Gufic BioSciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement in its financial performance and technical indicators. The upgrade, effective from 3 June 2026, follows a positive quarterly report for March 2026 and a shift in technical trends, signalling cautious optimism for investors in this small-cap pharmaceutical player."
      }
    ],
    "total": 575,
    "sid": "338998",
    "stock_news_url": "https://www.marketsmojo.com/news/gufic-biosciences-338998"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "18-Jun-2026",
      "details": "Newspaper Advertisement regarding Special Window for Re-lodgement of Transfer and Dematerialization of physical shares is attached herewith.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "05-Jun-2026",
      "details": "Written Transcript of Earnings Conference Call held on June 01 2026 at 04:30 PM is attached herewith.",
      "source": "BSE"
    },
    {
      "caption": "Corrigendum And Clarification To Intimation Dated May 29 2026 Regarding Subscription To Shares Of Saraswat Co-Operative Bank Limited",
      "datetime": "02-Jun-2026",
      "details": "Corrigendum and Collaboration to Intimation dated May 29 2026 regarding Subscription to Shares of Saraswat Co-operative Bank Limited is attached herewith",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Gufic BioSciences Ltd has declared <strong>10%</strong> dividend, ex-date: 22 Sep 25",
          "dt": "2025-09-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Gufic BioSciences Ltd is Rated Sell

2026-06-23 10:10:54

Gufic BioSciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 June 2026, providing investors with the most up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-16 08:01:56

Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflected in a downgrade of its Mojo Grade from Hold to Sell as of 11 June 2026. Despite a strong year-to-date return outperforming the Sensex, recent price action and technical indicators suggest a sideways trend with mixed signals, warranting a cautious stance among investors.

Read full news article

Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-06-15 08:01:29

Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent upgrade in technical trend, the company’s overall MarketsMOJO grade has been downgraded from Hold to Sell, reflecting a complex interplay of bullish and bearish signals across multiple timeframes and indicators.

Read full news article

Gufic BioSciences Gains 10.35%: 4 Key Factors Driving the Week’s Momentum

2026-06-14 12:04:11

Key Events This Week

1 June: Stock surges 3.67% to ₹347.20 despite Sensex decline

2 June: Mixed technical signals amid mildly bearish momentum

3 June: Upgrade to Hold rating following strong quarterly results

4 June: Technical momentum shifts to mildly bullish with 3.73% gain

5 June: Week closes at ₹369.55, up 3.65% on the day

Week Open

Rs.334.90

...

Read full news article

Gufic BioSciences Gains 0.47%: 3 Key Factors Driving the Week’s Mixed Momentum

2026-06-13 14:04:42

Key Events This Week

8 June: Stock rallies 1.83% despite Sensex decline

9 June: Continued strong gains, up 3.10%

10 June: Sharp 6.33% drop amid valuation recalibration

11 June: Valuation shifts signal price attractiveness change

12 June: Downgrade to Sell and technical momentum shifts

Week Open

Rs.369.55

...

Read full news article

Gufic BioSciences Ltd Downgraded to Sell Amid Mixed Technicals and Expensive Valuation

2026-06-12 08:03:44

Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 11 June 2026. The downgrade follows a comprehensive reassessment across four critical parameters: Quality, Valuation, Financial Trend, and Technicals. Despite some positive quarterly results, the company faces challenges in sustaining long-term growth and valuation concerns amid mixed technical signals.

Read full news article

Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-12 08:01:17

Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Recent technical indicators present a complex picture, with bullish signals on weekly charts contrasting bearish cues on monthly timeframes, prompting a reassessment of the stock’s near-term outlook.

Read full news article

Gufic BioSciences Ltd Valuation Shifts Signal Price Attractiveness Change Amid Sector Dynamics

2026-06-11 08:00:18

Gufic BioSciences Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change reflects evolving market perceptions and impacts the stock’s price attractiveness relative to its historical levels and peer group within the Pharmaceuticals & Biotechnology sector.

Read full news article

Gufic BioSciences Ltd Upgraded to Hold as Financial and Technical Trends Improve

2026-06-04 08:07:40

Gufic BioSciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement in its financial performance and technical indicators. The upgrade, effective from 3 June 2026, follows a positive quarterly report for March 2026 and a shift in technical trends, signalling cautious optimism for investors in this small-cap pharmaceutical player.

Read full news article

View All News